<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00445835</url>
  </required_header>
  <id_info>
    <org_study_id>P060902</org_study_id>
    <secondary_id>PHAO 2006</secondary_id>
    <nct_id>NCT00445835</nct_id>
  </id_info>
  <brief_title>Active Detection of the Extension of Atherothrombosis in High Risk Coronary Patients</brief_title>
  <acronym>AMERICA</acronym>
  <official_title>Active Detection and Management of the Extension of Atherothrombosis in High Risk Coronary Patients In Comparison With Standard of Care for Coronary Atherosclerosis: The AMERICA Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut de l'Atherothrombose</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronary artery disease is the first cause of death related to atherothrombosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronary artery disease is the first cause of death related to atherothrombosis. There is a
      close correlation between the extension of coronary artery disease and the severity of
      atherosclerotic lesions in extra coronary arterial beds. In addition, these symptomatic
      extracoronary lesions dramatically decrease the survival of these patients. However, scant
      data are available regarding the prevalence of extracoronary asymptomatic lesions.
      Conversely, the annual absolute risk of these lesions remains unknown. Consequently, whether
      a systematic identification of these extracoronary asymptomatic lesions is relevant remains
      to be established. The Primary Objective and Primary Endpoint of the AMERICA study is to
      demonstrate the superiority of an active detection and management of the extension of
      atherothrombosis in high Risk coronary patients (active strategy) in comparison with standard
      of care for coronary atherosclerosis (conservative strategy).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2007</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>death (all cause) or any ischemic event leading to rehospitalisation or any evidence of organ failure.</measure>
    <time_frame>during the study</time_frame>
    <description>death (all cause) or any ischemic event leading to rehospitalisation or any evidence of organ failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of each composite of the primary endpoint.</measure>
    <time_frame>during the study</time_frame>
    <description>Incidence of each composite of the primary endpoint.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">526</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>BA :Active arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A strategy of systematic screening of these extra-coronary asymptomatic lesions combined with a specific treatment if needed and an aggressive secondary prevention pharmacological treatment of atherothrombosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BC: Conservative arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Conservative medical approach</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Arterial doppler for screening asymptomatic and significant extracoronary arterial stenoses in all arterial beds</intervention_name>
    <description>A strategy of systematic screening of these extra-coronary asymptomatic lesions combined with a specific treatment if needed and an aggressive secondary prevention pharmacological treatment of atherothrombosis</description>
    <arm_group_label>BA :Active arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conservative arm</intervention_name>
    <description>Conservative medical approach</description>
    <arm_group_label>BC: Conservative arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Three vessel disease recently identified recently (&lt;6 month)

          2. Accrue coronary syndromes in patients&gt;75 years old (&lt;1 month)

        Exclusion criteria:

          1. Absence of significant coronary lesions

          2. Other causes of rise in the troponin level

          3. Patient&lt;18 years old

          4. Pregnant women

          5. Patient without affiliation to National Social Security
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Philippe COLLET, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Pitie-Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2007</study_first_submitted>
  <study_first_submitted_qc>March 8, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2007</study_first_posted>
  <last_update_submitted>September 30, 2010</last_update_submitted>
  <last_update_submitted_qc>September 30, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 1, 2010</last_update_posted>
  <responsible_party>
    <name_title>Yannick Vacher</name_title>
    <organization>Department Clinical Research of Developpement</organization>
  </responsible_party>
  <keyword>coronary artery disease</keyword>
  <keyword>myocardial infarction</keyword>
  <keyword>atherothrombosis</keyword>
  <keyword>atherosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

